Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Goodwill & Intangibles (2016 - 2025)

Haemonetics has reported Goodwill & Intangibles over the past 16 years, most recently at $1.0 billion for Q4 2025.

  • Quarterly results put Goodwill & Intangibles at $1.0 billion for Q4 2025, down 4.14% from a year ago — trailing twelve months through Dec 2025 was $1.0 billion (down 4.14% YoY), and the annual figure for FY2025 was $1.1 billion, up 9.14%.
  • Goodwill & Intangibles for Q4 2025 was $1.0 billion at Haemonetics, down from $1.0 billion in the prior quarter.
  • Over the last five years, Goodwill & Intangibles for HAE hit a ceiling of $1.1 billion in Q2 2024 and a floor of $715.9 million in Q3 2023.
  • Median Goodwill & Intangibles over the past 5 years was $826.0 million (2021), compared with a mean of $895.7 million.
  • Biggest five-year swings in Goodwill & Intangibles: soared 142.01% in 2021 and later fell 6.54% in 2022.
  • Haemonetics' Goodwill & Intangibles stood at $805.8 million in 2021, then decreased by 6.87% to $750.5 million in 2022, then skyrocketed by 31.15% to $984.3 million in 2023, then rose by 8.8% to $1.1 billion in 2024, then decreased by 4.14% to $1.0 billion in 2025.
  • The last three reported values for Goodwill & Intangibles were $1.0 billion (Q4 2025), $1.0 billion (Q3 2025), and $1.1 billion (Q2 2025) per Business Quant data.